Facebook
Twitter
LinkedIn
ForwardClick here to search courses using NAPNAP's previous Course Catalog layout.
Title
Category
Credits
Event date
Cost
- Primary Care
- Pharmacology CE
- 1.00 Contact hours
$10.00
1.0 NAPNAP Contact Hour of which 0.25 contain pharmacology content. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is $10 for NAPNAP Members. For non-members, this continuing education activity rate is $20. This course is a recorded presentation for NAPNAP's 2024 National Conference.
Sepsis remains one of the most frequent causes of pediatric morbidity and mortality. This presentation will address challenges in pediatric sepsis recognition and management, as well as provide education regarding care of the septic patient in various settings (e.g., emergency department, critical care, and post-sepsis care). Participants will be introduced to sepsis protocols currently being utilized within institutions across the country.
- Primary Care
- Acute Care
- Mental Health
- Bundle
- Professional Development
- Professional Issues
- Pharmacology CE
- Psychopharmacology CE
$199.00
You get 24 courses from NAPNAP's 2024 National Conference totaling 27 NAPNAP Contact Hours, 5.5 Pharmacology,1.25 Psychopharmacology and 2.5 Controlled Substance.
This continuing education activity is offered at a member-only discounted rate of $199, a cost-savings of more than $60.
Non-members may purchase this bundle for $500. Join NAPNAP before purchasing to save more than $300.
- FREE for Members
- Pharmacology CE
- 1.25 Contact hours
$10.00
1.25 NAPNAP contact hour of which 0.5 contain pharmacology content (Rx). This continuing education activity is offered free to NAPNAP Members. For nonmembers, this continuing education activity rate is $10.
Syphilis, a sexually transmitted infection caused by Treponema pallidum, has become a concerning resurgence in recent years, particularly in the United States. Of significant concern is the steep rise in congenital syphilis cases, which poses grave risks to maternal and neonatal health. This article provides an overview of the epidemiology, risk factors, clinical manifestations, screening methods, and treatment strategies for syphilis, with a specific focus on congenital transmission. Drawing upon current literature and guidelines, the paper underscores the importance of early detection and intervention to prevent adverse outcomes associated with congenital syphilis. Furthermore, the article highlights the challenges in syphilis diagnosis, including the interpretation of serological tests and the management of neurosyphilis. Recommendations for practice, including screening protocols and treatment regimens, are discussed in detail. The conclusion emphasizes the urgent need for collaborative efforts among healthcare providers, public health agencies, and community stakeholders to address the syphilis epidemic effectively. By adhering to evidence-based guidelines and leveraging available resources, clinicians can play a pivotal role in reducing the burden of syphilis and safeguarding the health of vulnerable populations, particularly pregnant women and infants.
J Pediatr Health Care. (2025) 39, 479-488.
- FREE for Members
- Pharmacology CE
- 1.00 Contact hours
$10.00
1.0 NAPNAP contact hour of which 0.5 contain pharmacology content (Rx). This continuing education activity is offered free to NAPNAP Members. For nonmembers, this continuing education activity rate is $10.
Allergic rhinoconjunctivitis (AR/C) is a common pediatric condition. The physical, emotional, and social burden of AR/C in children highlights the need for accurate diagnosis with optimal treatment. This review provides practical information on the diagnosis and management of pediatric AR/C. Key features of the patient history and physical exam needed to diagnose seasonal and perennial AR/C are covered. Various AR/C treatment options are reviewed such as allergen avoidance, pharmacotherapies, and allergy immunotherapy (both subcutaneous injections and sublingual tablets) as well as their mode of action, side effects, and their role in guideline-recommended therapy. Practical information such as pollen calendars, management algorithms, and treatment product characteristics have also been included in this review.
J Pediatr Health Care. (2025) 39, 489-502.
- FREE for Members
- Pharmacology CE
- 1.00 Contact hours
$10.00
1.0 NAPNAP contact hour of which 1.0 contain pharmacology content (Rx). This continuing education activity is offered free to NAPNAP Members. For nonmembers, this continuing education activity rate is $10.
Preexposure prophylaxis (PrEP) uptake remains low among adolescents and young adults at high risk due to various barriers, such as decreased access to care, human immunodeficiency virus (HIV) stigma, and misinformation. The barriers to the uptake of PrEP among adolescents and young adults are multifaceted and require comprehensive mitigation strategies. Presented is the epidemiology of HIV, pathophysiology, and complications of HIV in adolescents, history of PrEP research, “How to End the HIV Epidemic in the U.S.” plan, reviewing and eliminating barriers to PrEPcare, PrEP curriculum opportunities for the provider, and the role of the nurse practitioner in reducing new HIV diagnoses in adolescents.
J pediatr Health Care. (2025) 39, 503−514.
- Primary Care
- Bundle
$0.00
In this course bundle, three courses have been selected by the Childhood Obesity Prevention Special Interest Group (CO SIG) to increase knowledge related to AAP's 2023 Clinical Practice Guideline for the Evaluation and Treatment of Pediatric Obesity in Primary Care.
- Primary Care
- FREE for Members
- Pharmacology CE
- 1.00 Contact hours
$0.00
1.0 NAPNAP contact hour of which 0.25 contain pharmacology content. This continuing education activity is offered FREE to Members and Nonmembers.
The purpose of this program is to inform primary care pediatric health care providers about the management of children and adolescents with obesity guided by the American Academy of Pediatrics (AAP) Clinical Practice Guidelines published in 2023. The presentation content focuses on how to implement best practices for the management of children and adolescents with obesity including pharmacotherapy. Additionally, guidance on the AAP resources and how to access and utilize these tools will be discussed.
- Primary Care
- 1.00 Contact hours
$0.00
1.00 NAPNAP Contact Hour. This course is an archived session from NAPNAP's Pediatric Virtual Symposium: 2024 Targeted Topics.
The 2023 American Academy of Pediatrics (AAP) CPG for the Evaluation and Treatment of Obesity in Children and Adolescents recommends that children 2-18 years with overweight/obesity be comprehensively evaluated for comorbidities and offered multicomponent, family-based, Intensive Health Behavior and Lifestyle Treatment (IHBLT). This session will focus on the core components of IHBLT and the associated health outcomes. Additionally, participants will learn how to locate recognized Family Healthy Weight Programs and steps to take if there are no local programs. Led by a member of the AAP clinical practice guideline writing team and a member of the NAPNAP Childhood Obesity SIG, this session will help primary care providers assess and build their capacity around IHBLT.
Guidance for Primary Care PNPs During and After Medical/Surgical Treatment of Obesity in Adolescents
- Primary Care
- FREE for Members
- 1.00 Contact hours
$0.00
1.0 NAPNAP contact hour. This continuing education activity is offered FREE to Members and Nonmembers.
The American Academy of Pediatrics (AAP) recently released the ‘Clinical Practice Guideline (CPG) for the Evaluation and Treatment of Children and Adolescents with Obesity’ in early 2023. Updated from the AAP’s 2008 recommendations for prevention, assessment, and treatment of children and adolescents with overweight and obesity, the 2023 CPG offers expanded treatment recommendations which includes medication and surgical management. Pediatric Nurse Practitioners (PNP) may not understand the long-term management and support needs in primary care needed for this population. Discussion of management considerations for the primary care provider include: preventative care and screenings, health promotion, nutrition, body image, physical activity and psychological support. Additionally, recommendations for family and community involvement to support improved long-term care outcomes will be discussed.
- NAPNAP Cares
- Mental Health
- FREE for Members
- 1.25 Contact hours
$25.00
1.25 NAPNAP Contact Hour. This continuing education activity is part of NAPNAP Cares. The continuing education activity fee for non-members is $25. This course will discuss the evaluation, diagnostic decision making, and initial- and ongoing- management of autism spectrum disorders.